American Heart Association, Inc: October 1, 2012 Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, affecting 1.5% to 2.0% of the population in the developed world. The lifetime risk for the development of AF is ≈1 in 4 men and women aged ≥40 years.1,2 A 2.5- to 3.0-fold increase in the […]
The Metastatic Cancer of Electrophysiology⁎⁎ Since the first reports of ablation therapy being used to treat atrial fibrillation, the field has exploded with studies, new techniques, and new technologies (1). It is no wonder that such fervor is associated with this topic. Our medical options to maintain sinus rhythm have been generally poorly effective, riddled […]
Atrial fibrillation: the scope of the problem 29 Aug 08:30 – 10:00 Atrial fibrillation (AF) Abstract Session Tallinn – Village 7 Chairpersons: Dobromir DOBREV (Mannheim, DE), Antonio MADRID (Madrid, ES) Presentations list Time FP Nr Title Speakers Related documents 08:30 5296 Female gender and risk of stroke in atrial fibrillation: a nationwide cohort study Anders MIKKELSEN […]
The Loire Valley Atrial Fibrillation Project Management decisions for thromboprophylaxis in atrial fibrillation need to balance the risk of stroke against serious hemorrhage. The objective of the present analysis is to compare the Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (>65 years), Drugs/alcohol concomitantly (HAS-BLED) score against other […]
Circ.ahajournals.org: 10/9/12 Background—Premature atrial contractions (PACs) are independent predictors of atrial fibrillation, stroke and death. However, little is known about PAC frequency in the general population and its association with other cardiovascular risk factors. Methods and Results—We performed a cross-sectional analysis among participants of the population-based Swiss cohort Study on Air Pollution and […]
Plosone.org: 10/9/12 Apixaban was shown to be superior to adjusted-dose warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation (AF) and at least one additional risk factor for stroke, and associated with reduced rates of hemorrhage. We sought to determine the cost-effectiveness of using apixaban for stroke prevention. Methods Based on the […]
Content.onlinejacc.org 10/1/12 Objectives This study describes the 5-year efficacy of catheter ablation for long-standing persistent atrial fibrillation (LS-AF). Background Long-term outcome data after catheter ablation for LS-AF are limited. Methods Long-term follow-up of 56 months (range 49 to 67 months) was performed in 202 patients (age 61 ± 9 years) who underwent the sequential ablation strategy for symptomatic […]
Sciencedirect.com: October 6, 2012 The incidence and prevalence of atrial fibrillation are quickly increasing, mainly due to the ageing of the population. Atrial fibrillation is, to date, a problem of public health. Atrial fibrillation is associated to a five-fold risk of stroke, which may be identified by score risks, such as CHADS2 score. The classical antithrombotic treatment […]
Cmaj.ca: October 1, 2012 Moderate alcohol consumption may reduce cardiovascular events, but little is known about its effect on atrial fibrillation in people at high risk of such events. We examined the association between moderate alcohol consumption and the risk of incident atrial fibrillation among older adults with existing cardiovascular disease or diabetes. Methods: We analyzed data […]
Circ.ahajournals.org: October 2, 2012 One sixth of U.S. dialysis patients older than 65 years have been diagnosed with atrial fibrillation/flutter (AF). Little is known, however, about the incidence of AF in this population. Methods and Results—We identified 258,605 older patients (≥67 years) with fee-for-service Medicare initiating dialysis in 1995-2007, who had not been diagnosed with AF […]
